Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
5.09
-0.11 (-2.12%)
Apr 28, 2025, 11:36 AM EDT - Market open
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $204.86 million as of April 28, 2025. Its market cap has decreased by -36.56% in one year.
Market Cap
204.86M
Enterprise Value
164.28M
1-Year Change
-36.56%
Ranking
Category
Stock Price
$5.09
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $204.86M, a decrease of -84.64%. That is a compound annual growth rate of -33.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 209.29M | -21.94% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |